Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate

Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma

(2018) Cheng-Wen Lin et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential

(2015) Yangbo Feng et al.   JOURNAL OF MEDICINAL CHEMISTRY

Design, Synthesis, and Biological Evaluation of Novel, Highly Active Soft ROCK Inhibitors

(2015) Sandro Boland et al.   JOURNAL OF MEDICINAL CHEMISTRY

A Simplified Up-Down Method (SUDO) for Measuring Mechanical Nociception in Rodents Using von Frey Filaments

(2014) Robert P Bonin et al.   Molecular Pain

Rho kinase and hypertension

(2010) Angela Wirth   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The development of benzimidazoles as selective rho kinase inhibitors

(2010) E. Hampton Sessions et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Benzothiazoles as Rho-associated kinase (ROCK-II) inhibitors

(2009) Yan Yin et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice

(2009) Jing Ding et al.   MOLECULAR AND CELLULAR NEUROSCIENCE